Back to Search Start Over

Immune response with long-term memory triggered by amorphous aggregates of misfolded anti-EGFR V HH -7D12 is directed against the native V HH -7D12 as well as the framework of the analogous V HH -9G8.

Authors :
Golam Kibria M
Akazawa-Ogawa Y
Hagihara Y
Kuroda Y
Source :
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2021 Aug; Vol. 165, pp. 13-21. Date of Electronic Publication: 2021 May 08.
Publication Year :
2021

Abstract

We previously demonstrated that amorphous aggregates of misfolded V <subscript>HH</subscript> -7D12 antibodies (V <subscript>HH</subscript> -Mis), a potential anti-EGFR drug, can generate a robust serum IgG response. Here we investigate the immunogenic nature, especially the specificity of the immune response induced by V <subscript>HH</subscript> -Mis. To this end, we used two natively folded and 77% identical anti-EGFR V <subscript>HH</subscript> s (V <subscript>HH</subscript> -7D12 and V <subscript>HH</subscript> -9G8) that possess a common framework but distinct complementarity determining regions (CDRs). In 60% of mice immunized with V <subscript>HH</subscript> -Mis, the anti-V <subscript>HH</subscript> -7D12 IgG titer was stronger than the anti-V <subscript>HH</subscript> -9G8 titer (Group-1). In the remaining mice (40%; Group-2), the anti-V <subscript>HH</subscript> -7D12 and anti-V <subscript>HH</subscript> -9G8 titer were almost identical. We rationalized these results by hypothesizing that mice in Group-1 produced IgG mostly against the V <subscript>HH</subscript> -7D12's CDRs, whereas in Group-2 mice, they targeted the V <subscript>HH</subscript> 's framework. The IgG specificity against V <subscript>HH</subscript> -7D12 and V <subscript>HH</subscript> -9G8 was essentially unchanged over 17 weeks in both groups. Further, in all mice (Group-1&2) re-immunized with native V <subscript>HH</subscript> -7D12, the IgG titer against V <subscript>HH</subscript> -7D12 increased sharply but not against V <subscript>HH</subscript> -9G8. On the other hand, none of the three Group-1 mice re-immunized with native V <subscript>HH</subscript> -9G8 showed immunogenicity against V <subscript>HH</subscript> -7D12 nor V <subscript>HH</subscript> -9G8. Whereas, in Group-2 mice (three/three) re-immunized with V <subscript>HH</subscript> -9G8, the IgG titers against both V <subscript>HH</subscript> s increased but slowly. Flow-cytometric studies showed that V <subscript>HH</subscript> -Mis immunized mice generated a higher number of effector and central memory T-cells. Overall, these observations indicate that amorphous aggregates made of a misfolded V <subscript>HH</subscript> can induce serum IgG against its natively folded self and analogous V <subscript>HH</subscript> s having a similar framework but distinct CDRs. Furthermore, a robust long-term immune response with memory was established against its natively folded self but with a nil-to-moderate immune response against natively folded V <subscript>HH</subscript> analogs.<br /> (Copyright © 2021 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1873-3441
Volume :
165
Database :
MEDLINE
Journal :
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Publication Type :
Academic Journal
Accession number :
33971271
Full Text :
https://doi.org/10.1016/j.ejpb.2021.05.004